334 related articles for article (PubMed ID: 18347172)
1. Prognostic value of body mass index in locally advanced breast cancer.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cristofanilli M; Valero V; Buzdar AU; Kau SW; Broglio KR; Gonzalez-Angulo AM; Sneige N; Islam R; Ueno NT; Buchholz TA; Singletary SE; Hortobagyi GN
Cancer; 2007 Oct; 110(7):1436-44. PubMed ID: 17694554
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of initial clinical disease stage after achieving pathological complete response.
Dawood S; Broglio K; Kau SW; Islam R; Symmans WF; Buchholz TA; McGuire SE; Meric-Bernstam F; Cristofanilli M; Hortobágyi GN; Gonzalez-Angulo AM
Oncologist; 2008 Jan; 13(1):6-15. PubMed ID: 18245008
[TBL] [Abstract][Full Text] [Related]
4. Impact of a raised body mass index on breast cancer survival in relation to age and disease extent at diagnosis.
Imkampe AK; Bates T
Breast J; 2010; 16(2):156-61. PubMed ID: 19968656
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
[TBL] [Abstract][Full Text] [Related]
6. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
Skírnisdóttir I; Sorbe B
Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
[TBL] [Abstract][Full Text] [Related]
7. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
10. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
11. Trends for inflammatory breast cancer: is survival improving?
Gonzalez-Angulo AM; Hennessy BT; Broglio K; Meric-Bernstam F; Cristofanilli M; Giordano SH; Buchholz TA; Sahin A; Singletary SE; Buzdar AU; Hortobágyi GN
Oncologist; 2007 Aug; 12(8):904-12. PubMed ID: 17766649
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on survival in epithelial ovarian cancer.
Pavelka JC; Brown RS; Karlan BY; Cass I; Leuchter RS; Lagasse LD; Li AJ
Cancer; 2006 Oct; 107(7):1520-4. PubMed ID: 16941453
[TBL] [Abstract][Full Text] [Related]
15. Is obesity an independent prognosis factor in woman breast cancer?
Majed B; Moreau T; Senouci K; Salmon RJ; Fourquet A; Asselain B
Breast Cancer Res Treat; 2008 Sep; 111(2):329-42. PubMed ID: 17939036
[TBL] [Abstract][Full Text] [Related]
16. Association of overweight with breast cancer survival.
Tao MH; Shu XO; Ruan ZX; Gao YT; Zheng W
Am J Epidemiol; 2006 Jan; 163(2):101-7. PubMed ID: 16339054
[TBL] [Abstract][Full Text] [Related]
17. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma.
Demirkan B; Alacacioglu A; Yilmaz U
Jpn J Clin Oncol; 2007 Apr; 37(4):256-65. PubMed ID: 17553816
[TBL] [Abstract][Full Text] [Related]
18. Does obesity have an effect on outcomes in triple-negative breast cancer?
Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
[TBL] [Abstract][Full Text] [Related]
19. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF;
Gynecol Oncol; 2007 Apr; 105(1):59-65. PubMed ID: 17150247
[TBL] [Abstract][Full Text] [Related]
20. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
